GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TYK Medicines Inc (HKSE:02410) » Definitions » 5-Year Yield-on-Cost %

TYK Medicines (HKSE:02410) 5-Year Yield-on-Cost % : 0.00 (As of May. 03, 2025)


View and export this data going back to 2024. Start your Free Trial

What is TYK Medicines 5-Year Yield-on-Cost %?

TYK Medicines's yield on cost for the quarter that ended in Dec. 2024 was 0.00.


The historical rank and industry rank for TYK Medicines's 5-Year Yield-on-Cost % or its related term are showing as below:



HKSE:02410's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.685
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of TYK Medicines's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, TYK Medicines's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TYK Medicines's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TYK Medicines's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where TYK Medicines's 5-Year Yield-on-Cost % falls into.


;
;

TYK Medicines 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of TYK Medicines is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

TYK Medicines  (HKSE:02410) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


TYK Medicines 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of TYK Medicines's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


TYK Medicines Business Description

Traded in Other Exchanges
N/A
Address
No. 1278 Mingzhu Road, Room 1403-2, Floor 14, Tower A, Changxing World Trade Building, Zhejiang Province, Changxing Economic Development Zone, Huzhou, CHN
TYK Medicines Inc is a drug discovery research and development centre. The company and its subsidiaries are principally engaged in the research, development and commercialization of pharmaceutical products.
Executives
Nan Jing Yi Da Tou Zi Guan Li You Xian Gong Si
Nan Jing Yi Da Zi Ben Guan Li Qi Ye You Xian He Huo
Jiang Su Yi Da Gu Quan Tou Zi Ji Jin Guan Li You Xian Gong Si
Wu Yusheng 2201 Interest of corporation controlled by you
Zhu Julia Ming 2202 Interest of your spouse
Zheng Zhou Tai Ji Hong Nuo Yi Yao Gu Fen You Xian Gong Si 2101 Beneficial owner
Zhang Xing Li Yuan Qi Ye Guan Li He Huo Qi Ye You Xian He Huo 2101 Beneficial owner
He Chao 2201 Interest of corporation controlled by you
Bei Jing Hou Ji Jing Qiao Chuang Ye Tou Zi You Xian Gong Si 2201 Interest of corporation controlled by you
Bei Jing Rong Chen Hou Ji Tou Zi Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Zhang Xing Xing Zhang Chan Ye Tou Zi He Huo Qi Ye You Xian He Huo 2101 Beneficial owner

TYK Medicines Headlines

No Headlines